ProMIS Neurosciences, Inc. (NASDAQ:PMN – Get Free Report)’s share price was down 5% during trading on Friday . The company traded as low as $1.30 and last traded at $1.30. Approximately 16,788 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 70,167 shares. The stock had previously closed at $1.37.
ProMIS Neurosciences Stock Performance
The company has a market capitalization of $24.65 million, a price-to-earnings ratio of -1.76 and a beta of 0.62. The business’s 50 day moving average is $1.58 and its 200 day moving average is $1.79.
ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. Sell-side analysts predict that ProMIS Neurosciences, Inc. will post -0.24 EPS for the current year.
ProMIS Neurosciences Company Profile
ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Read More
- Five stocks we like better than ProMIS Neurosciences
- Best Aerospace Stocks Investing
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- Retail Stocks Investing, Explained
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- Want to Profit on the Downtrend? Downtrends, Explained.
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for ProMIS Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMIS Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
